Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)

PHASE3

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated by Sponsor as a result of a business decision to discontinue the development program for MK-8342B for reasons unrelated to safety or efficacy.

Conditions

Moderate to Severe Primary Dysmenorrhea

Interventions

DRUG: Etonogestrel (ENG) 125 μg + 17β-estradiol (E2) 300 μg vaginal ring
DRUG: Placebo vaginal ring
DRUG: Ibuprofen

Sponsor

Organon and Co